Journals – 2013

 

2018   2017   2016    2015    2014    2013    2012    2011    2010    2009     2008     2007    2006    2001-2005    1996-2000    

  

Cantisani M, Falanga A, Incoronato N, Russo L, De Simone A, Morelli G, Berisio R, Galdiero M, Galdiero S.* Conformational modifications of gB from Herpes simplex virus type 1 analyzed by synthetic peptides. J Med Chem. 2013, 56(21):8366-76. *Corresponding authors

Gaikwad S, Ingle A, Gade A, Rai1 M, Falanga A, Incoronato N, Russo L, Galdiero S*, and Galdiero M. Antiviral activity of mycosynthesized silver nanoparticles against Herpes Simplex virus and Human Parainfluenza Virus Type 3. J. Nanomed. 2013, 8:4303-14. *Corresponding authors

Galdiero S,* Falanga A, Cantisani M, Vitiello M, Morelli G, Galdiero M. Peptide-lipid interactions: experiments and applications J. Mol. Sci. 2013, 14, 1-24. *Corresponding author

Cantisani, Leone M, Mignogna E, Kampanaraki K, Falanga A, Morelli G, Galdiero M, Galdiero S.* Structure activity relations of Myxinidin, an antibacterial peptide derived from Epidermal Mucus of Hagfish. Antimicrobial Agents and Chemotherapy, 2013, 57,11, 5665-5673. *Corresponding author

Guarnieri, A. Falanga, O. Muscetti, R. Tarallo, S. Fusco, M. Galdiero, S. Galdiero*, P.A. Netti PA.*. Shuttle-Mediated Nanoparticle Delivery to the Blood-Brain Barrier. Small. 2013, 9, 6, 853-862. *Corresponding authors

Falanga, A., Tarallo, R., Galdiero, E., Cantisani, M., Galdiero, M., Galdiero, S.* Review of a viral peptide nanosystem for intracellular delivery Journal of Nanophotonics 2013, 7 (1) , art. no. 071599. *Corresponding authors

Vitiello, Fragneto G, Petruk AA, Falanga A, Galdiero S, D’Ursi A, Merlino A and D’Errico G. Cholesterol modulates the fusogenic activity of a membranotropic domain of the FIV glycoprotein gp36 Soft Matter, 2013, 9, 6442-6456

Smaldone G, Falanga A, Capasso D, Guarnieri D, Correale S, Galdiero M, Netti PA, Zollo M, Galdiero S, Di Gaetano S, Pedone E. gH625 is a viral derived peptide for effective delivery of intrinsically disordered proteins. Int J Nanomedicine. 2013, 8, 2555-65.

Tarallo R, Carberry TP, Falanga A, Vitiello M, Galdiero S, Galdiero M, Weck M. Dendrimers functionalized with membrane-interacting peptides for viral inhibition. Int J Nanomedicine. 2013, 8, 521-34.

Galdiero S*, Falanga A, Tarallo R, Russo L, Galdiero E, Cantisani M, Morelli G, Galdiero M. Peptide inhibitors against herpes simplex virus infections. J Pept Sci. 2013, 19, 3, 148-58. *Corresponding authors

Scudiero O, Galdiero S, Nigro E, Del Vecchio L, Di Noto R, Cantisani M, Colavita I, Galdiero M, Cassiman JJ, Daniele A, Pedone C, Salvatore F. Chimeric beta-defensin analogs, including the novel 3NI analog, display salt-resistant antimicrobial activity and lack toxicity in human epithelial cell lines. Antimicrob Agents Chemother, 2013, 57, 4, 1701-8.

de Antonellis P, Liguori L, Falanga A, Carotenuto M, Ferrucci V, Andolfo I, Marinaro F, Scognamiglio I, Virgilio A, De Rosa G, Galeone A, Galdiero S, Zollo M. MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines. Naunyn Schmiedebergs Arch Pharmacol. 2013, 386, 4, 287-302.